Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors-Reference-Cited by-同舟云学术

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

Published:2002-08-15 Issue:7 Volume:347 Page:472-480
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Demetri George D.,von Mehren Margaret,Blanke Charles D.,Van den Abbeele Annick D.,Eisenberg Burton,Roberts Peter J.,Heinrich Michael C.,Tuveson David A.,Singer Samuel,Janicek Milos,Fletcher Jonathan A.,Silverman Stuart G.,Silberman Sandra L.,Capdeville Renaud,Kiese Beate,Peng Bin,Dimitrijevic Sasa,Druker Brian J.,Corless Christopher,Fletcher Christopher D.M.,Joensuu Heikki

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa020461

Cited by 3707 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small bowel cancers: A population-based analysis of epidemiology, treatment and outcomes in Ontario, Canada from 2005-2020;Surgical Oncology Insight;2024-12

2. Intratumoral microbiome promotes liver metastasis and dampens adjuvant imatinib treatment in gastrointestinal stromal tumor;Cancer Letters;2024-10

3. Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor;International Immunopharmacology;2024-10

4. Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events;Molecular Metabolism;2024-10

5. A clinician’s guide to effects of obesity on childhood asthma and into adulthood;Expert Review of Respiratory Medicine;2024-09-11